Progesterone receptor transcription and non-transcription signaling mechanisms

Steroids

Volumn 68, Issue 10-13, 2003, Pages 761-770

  Leonhardt, Susan A ^a   Boonyaratanakornkit, Viroj ^a   Edwards, Dean P ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Antagonists; Cell signaling; Progesterone receptor; Steroid; Transcription; Tyrosine kinase

Indexed keywords

8 BROMO CYCLIC AMP; ANTIGESTAGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GESTAGEN; MIFEPRISTONE; ONAPRISTONE; POSTCOITUS CONTRACEPTIVE AGENT; PROGESTERONE RECEPTOR; PROMEGESTONE;

BINDING AFFINITY; CELL MEMBRANE; CONFERENCE PAPER; CYTOPLASM; DIMERIZATION; DNA BINDING; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; DRUG BINDING; DRUG MECHANISM; DRUG POTENCY; ENDOMETRIOSIS; GENETIC TRANSCRIPTION; HUMAN; LIGAND BINDING; MENINGIOMA; NONHUMAN; SIGNAL TRANSDUCTION; UTERUS MYOMA;

EID: 0347627644     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(03)00129-6     Document Type: Conference Paper

References (59)

1. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:2000;121-141.
2. Edwards D. Coregulatory proteins in steroid hormone receptor action. Vitam. Horm. 55:1999;165-218.
3. McKenna N.J., O'Malley B.W. Combinational control of gene expression by nuclear receptors and coregulators. Cell. 108:2002;465-474.
4. Migliaccio A., Piccolo D., Castoria G., Di Domenico M., Bilancio A., Lombardi M.et al. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17:1998;2008-2018.
5. Boonyaratanakornkit V., Scott M.P., Ribon V., Sherman L., Anderson S.M., Miller W.T.et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell. 8:2001;269-280.
6. Ferrell J.E. Xenopus oocyte maturation: new lessons from a good egg. Bio. Essays. 21:1999;833-842.
7. Cheung J., Smith D.F. Molecular chaparone interactions with steroid receptors: an update. Mol. Endocrinol. 14:2000;939-946.
8. Tsai M., O'Malley B. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
9. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H.et al. Two distinct estrogen-regulated promoters generate transcripts encoding two functionally different human progesterone receptor forms A and B. EMBO J. 9:1990;1603-1614.
10. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 277:2002;5209-5218.
11. Giangrande P.H., McDonnell D.P. The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene. Rec. Prog. Horm. Res. 54:1999;291-313.
12. Sartorius C.A., Melville M.Y., Hovland A.R., Tung L., Takimoto G.S., Horwitz K.B. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol. Endocrinol. 8:1994;1347-1360.
13. Leonhardt S.A., Edwards D.P. Mechanism of action of progesterone antagonists. Exp. Biol. Med. 227:2002;969-980.
14. McDonnell D.P., Vegeto E., O'Malley B.W. Identification of a negative regulatory function for steroid receptors. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10563-10567.
15. Benhamou B., Garcia T., Lerouge T., Vergezac A., Gofflo D., Bigogne C.et al. A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science. 225:1992;206-209.
16. Baulieu E.-E. Contragestion and other clinical applications of RU486, an antiprogesterone at the receptor. Science. 245:1989;1351-1357.
17. DeMarzo A.M., Onate S.A., Nordeen S.K., Edwards D.P. Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor. Biochemistry. 31:1992;10491-10501.
18. Skafar D. Differences in the binding mechanism of RU486 and progesterone to the progesterone receptor. Biochemistry. 30:1991;10829-10832.
19. Kuhnel B., El Ashry D., Edwards D.P., Nordeen S.K. Mapping contacts between unpurified human progesterone receptor and the hormone response element of mouse mammary tumor virus. DNA. 10:1989;703-713.
20. Chalepakis G., Arnemann J., Slater E., Bruller H.J., Gross B., Beato M. Differential gene activation by glucocorticoids and progestins through the hormone regulatory element of mouse mammary tumor virus. Cell. 53:1988;371-382.
21. Delabre K.A.G.-M., Milgorm E. In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4421-4425.
22. Gass E.-K., Leonhardt S., Nordeen S., Edwards D. The antagoists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation. Endocrinology. 139:1998;1905-1919.
23. Klein-Hitpass L., Cato A., Henderson D., Ryffel G. Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T74D cells. Nucleic Acid Res. 19:1991;1227-1234.
24. Onate S., Tsai S., Tsai M., O'Malley B. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357.
25. El-Ashry D., Onate S., Nordeen S.K., Edwards D.P. Human progesterone receptor complexes with the antagonist RU486 bind to a hormone response element in a structurally altered form. Mol. Endocrinol. 3:1989;1545-1558.
26. Allan G., Tsai S., Tsai M.-J., O'Malley B. Ligand-dependent conformational changes in the progesterone receptor are neccesary for events that follow DNA binding. Proc. Natl. Acad. Sci. U.S.A. 89:1992;11750-11754.
27. Williams S.P., Sigler P.B. Atomic structure of progesterone complexed with its receptor. Nature. 393:1998;392-396.
28. Tanebaum D., Wang Y., Willams S., Sigler P. Crystallographic comparison of the estrogen and progestorone receptor's ligand binding domains. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5998-6003.
29. Kraus W.L., McInerney E.M., Katzenellenbogen B.S. Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc. Natl. Acad. Sci. U.S.A. 92:1995;12314-12318.
30. He B., Kemppainen J.A., Wilson E.M. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J. Biol. Chem. 275:2000;22986-22994.
31. Tetel M.J., Giangrande P.H., Leonhardt S.A., McDonnell D.P., Edwards D.P. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol. Endocrinol. 13:1999;910-924.
32. Bamberger A.-M., Bamberger C., Gellersen B., Schulte H.M. Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6169-6174.
33. Kalkhoven E., Wissink S., van der Saag P.T., van der Burg B. Negative interation between the RelA(p65) subunit of NF-κB and the progesterone receptor. J. Biol. Chem. 271:1996;6217-6224.
34. Christian M., Pohnke Y., Kempf R., Gellersen B., Brosens J.J. Functional association of PR and CCAAT/enhancer-binding protein β isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells. Mol. Endocrinol. 16:2002;141-154.
35. Edwards D.P., Leonhardt S.A., Gass-Handel E. Novel mechanisms of progesterone antagonists and progesterone receptor. J. Soc. Gynecol. Investig. 7:2000;22-24.
36. Edwards D.P., Altmann M., DeMarzo A., Zhang Y., Weigel N.L., Beck C.A. Progesterone receptor and the mechanism of action of progesterone antagonists. J. Steroid Biochem. Mol. Biol. 53:1995;449-458.
37. Leonhardt S.A., Altmann M., Edwards D.P. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay. Mol. Endocrinol. 12:1998;1914-1930.
38. Meyer M.-E., Pornon A., Ji J., Bocquel M.-T., Chambon P., Gronemeyer H. Agoinstic and antagonistic activities of RU486 on the function of the human progesterone receptor. EMBO J. 9:1990;3923-3932.
39. Jackson T.A., Richer J.K., Bain D.L., Takimoto G.S., Tung L., Horwitz K.B. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol. Endocrinol. 11:1997;693-705.
40. Zhang X., Jeyakumar M., Petukhov S., Bagchi M.K. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol. Endocrinol. 12:1998;513-524.
41. Wagner B.L., Norris J.D., Knotts T.A., Weigel N.L., McDonnell D.P. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol. Cell Biol. 18:1998;1369-1378.
42. Wagner B.L., Pollio G., Leonhardt S.A., Wani M.C., Lee D.Y.-W., Imhof M.O.et al. 16α-Substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity. Proc. Natl. Acad. Sci. U.S.A. 93:1996;8739-8744.
43. Tung L., Mohamed M.K., Hoeffler J.P., Takimoto G.S., Horwitz K.B. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominately inhibited by A-receptors. Mol. Endocrinol. 7:1993;1256-1265.
44. Beck C., Estes P., Bona B. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. Endocrinology. 133:1993;728-740.
45. Sartorius C.A., Tung L., Takimoto G.S., Horwitz K.B. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. J. Biol. Chem. 268:1993;9262-9266.
46. Rowan B.G., Garrison N., Weigel N., O'Malley B. 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol. Cell Biol. 23:2000;8720-8730.
47. Onate S., Boonyaratanakornkit V., Spencer T., Tsai S., Tsai M.-J., Edwards D.et al. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domain of steroid receptors. J. Biol. Chem. 273:1998;12101-12108.
48. Lanz R.B., McKenna N.J., Onate S.A., Albrecht U., Wong J., Tsai S.Y.et al. The steroid coactivator, SRA, functions as a RNA and is present in an SRC-1 complex. Cell. 1:1999;17-27.
49. Wardell S.E., Boonyaratanakornkit V., Adelman J.S., Aronheim A., Edwards D.P. Jun dimerization protein-2 (JDP-2) functions as a progesterone receptor N-terminal domain coactivator. Mol. Cell Biol. 22:2002;5451-5466.
50. Katzenellenbogen B.S., Katzenellenbogen J.A. Defining the "S" in SERMs. Science. 295:2002;2380-2381.
51. Bayaa M., Booth R.A., Sheng Y., Liu X.J. The classical progesterone receptor mediates Xenopus oocyte maturation through a nongenomic mechansim. Proc. Natl. Acad. Sci. U.S.A. 97:2000;12607-12612.
52. Tian J., Kim S., Heilig E., Ruderman J.V. Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation. Proc. Natl. Acad. Sci. U.S.A. 97:2000;14358-14363.
53. McEwen B.S. Non-genmomic and genomic effects of steroids on neural activity. TIPS Rev. 12:1991;141-147.
54. Brown M.T., Copper J.A. Regulation, substrates and function of Src. Biochem. Biophys. Acta. 1287:1996;121-149.
55. Thomas S.N., Brugge J.S. Celluar functions regulated by Src family kinases. Ann. Rev. Cell Dev. Biol. 13:1997;513-609.
56. Schindler T., Sicheri F., Pico A., Gazit A., Levitzki A., Kuriyan J. Crystal structure of Hck in complex with a Src family selective tyrosine kinase inhibitor. Mol. Cell. 3:1999;639-648.
57. Xu W., Doshi A., Lei M., Eck M.J., Harrison S.C. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell. 3:1999;629-638.
58. Moarefi I., LaFevre-Bernt M., Sicheri F., Huse M., Lee C.-H., Kuriyan J.et al. Activation of the Src-family tyrosine kinase by SH3 domain displacement. Nature. 385:1997;650-653.
59. Musgrove E.A., Swarbrick A., Lee C.S.L., Cornish A.L., Sutherland R.L. Mechanisms of cyclin-dependent kinase inactivation by progestins. Mol. Cell Biol. 18:1998;1812-1825.